80_FR_39270 80 FR 39140 - Center for Scientific Review; Notice of Closed Meeting

80 FR 39140 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 130 (July 8, 2015)

Page Range39140-39140
FR Document2015-16706

Federal Register, Volume 80 Issue 130 (Wednesday, July 8, 2015) 
[Federal Register Volume 80, Number 130 (Wednesday, July 8, 2015)]
[Notices]
[Page 39140]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-16706]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Clinical Evaluation of Adjuncts to Opioid Therapies for the 
Treatment of Chronic Pain.
    Date: July 30, 2015.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: M. Catherine Bennett, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5182, MSC 7846, Bethesda, MD 
20892, 301-435-1766, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: July 1, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-16706 Filed 7-7-15; 8:45 am]
 BILLING CODE 4140-01-P

39140 Federal Register / Vol. 80, No. 130 / Wednesday, July 8, 2015 / Notices resources within the institute. The Name of Committee: National Institute of individuals associated with the grant information was discussed at the public Diabetes and Digestive and Kidney Diseases applications, the disclosure of which portion of the National Advisory Special Emphasis Panel; Disordered Eating. would constitute a clearly unwarranted Date: July 30, 2015. Council on Alcohol Abuse and invasion of personal privacy. Time: 1:30 p.m. to 3:00 p.m. Alcoholism held on June 10, 2015. Agenda: To review and evaluate grant Name of Committee: Center for Scientific DATES: This online presentation will be applications. Review Special Emphasis Panel, Clinical available at http://www.niaaa.nih.gov/ Place: National Institutes of Health, Two Evaluation of Adjuncts to Opioid Therapies sites/default/files/Reorg_ Democracy Plaza, 6707 Democracy for the Treatment of Chronic Pain. creationMedDevDivCouncil_ Boulevard, Bethesda, MD 20892, (Telephone Date: July 30, 2015. June2015final_Accessible.pdf on July 8, Conference Call). Time: 2:00 p.m. to 4:00 p.m. 2015 at 8:00 a.m. Members of the public Contact Person: Ann A. Jerkins, Ph.D., Agenda: To review and evaluate grant Scientific Review Officer, Review Branch, applications. wishing to provide comments must do DEA, NIDDK, National Institutes of Health, Place: National Institutes of Health, 6701 so by 5:00 p.m. EDT July 17, 2015 by Room 759, 6707 Democracy Boulevard, Rockledge Drive, Bethesda, MD 20892, sending an email to Bethesda, MD 20892–5452, 301–594–2242, (Telephone Conference Call). NIAAAReOrgComments@mail.nih.gov. jerkinsa@niddk.nih.gov. Contact Person: M. Catherine Bennett, The email should include your name Name of Committee: National Institute of Ph.D., Scientific Review Officer, Center for and, when applicable, your professional Diabetes and Digestive and Kidney Diseases Scientific Review, National Institutes of affiliation. NIAAA will respond to your Special Emphasis Panel; RFA–DK–14–023 Health, 6701 Rockledge Drive, Room 5182, email by July 24, 2015. Elucidating HIV and HIV-treatment MSC 7846, Bethesda, MD 20892, 301–435– FOR FURTHER INFORMATION CONTACT: Associated Metabolic/Endocrine Dysfunction 1766, bennettc3@csr.nih.gov. Keith Lamirande, Executive Officer, (R01). (Catalogue of Federal Domestic Assistance Date: July 31, 2015. Program Nos. 93.306, Comparative Medicine; Keith.Lamirande@nih.gov (301) 443– Time: 1:00 p.m. to 4:00 p.m. 93.333, Clinical Research, 93.306, 93.333, 2238 or Vicki Buckley, Deputy Agenda: To review and evaluate grant 93.337, 93.393–93.396, 93.837–93.844, Executive Officer, Vicki.Buckley@ applications. 93.846–93.878, 93.892, 93.893, National nih.gov (301) 443–1269, National Place: National Institutes of Health, Two Institutes of Health, HHS) Institute on Alcohol Abuse and Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Dated: July 1, 2015. Alcoholism, 5635 Fishers Lane, Rockville, MD 20852. Conference Call). David Clary, SUPPLEMENTARY INFORMATION: The NIH Contact Person: Ann A. Jerkins, Ph.D., Program Analyst, Office of Federal Advisory Scientific Review Officer, Review Branch, Committee Policy. Reform Act of 2006 (42 U.S.C. 281 DEA, NIDDK, National Institutes of Health, (d)(4)) requires public notice of [FR Doc. 2015–16706 Filed 7–7–15; 8:45 am] Room 759, 6707 Democracy Boulevard, proposed reorganization plans. Bethesda, MD 20892–5452, 301–594–2242, BILLING CODE 4140–01–P Information about those plans are jerkinsa@niddk.nih.gov. available on the Institute’s Web site, (Catalogue of Federal Domestic Assistance http://www.niaaa.nih.gov/. DEPARTMENT OF HEALTH AND Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; HUMAN SERVICES Dated: July 1, 2015. George Koob, 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology National Institutes of Health Director, National Institute on Alcohol Abuse and Hematology Research, National Institutes and Alcoholism. of Health, HHS) Center for Scientific Review; Notice of [FR Doc. 2015–16708 Filed 7–7–15; 8:45 am] Closed Meeting Dated: July 1, 2015. BILLING CODE 4140–01–P David Clary, Pursuant to section 10(d) of the Program Analyst, Office of Federal Advisory Federal Advisory Committee Act, as Committee Policy. amended (5 U.S.C. App.), notice is DEPARTMENT OF HEALTH AND [FR Doc. 2015–16704 Filed 7–7–15; 8:45 am] hereby given of the following meeting. HUMAN SERVICES BILLING CODE 4140–01–P The meeting will be closed to the National Institutes of Health public in accordance with the provisions set forth in sections National Institute of Diabetes and DEPARTMENT OF HEALTH AND 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Digestive and Kidney Diseases; Notice HUMAN SERVICES as amended. The grant applications and of Closed Meetings the discussions could disclose National Institutes of Health confidential trade secrets or commercial Pursuant to section 10(d) of the property such as patentable material, Federal Advisory Committee Act, as Center for Scientific Review; Notice of and personal information concerning amended (5 U.S.C. App.), notice is Closed Meeting individuals associated with the grant hereby given of the following meetings. The meetings will be closed to the Pursuant to section 10(d) of the applications, the disclosure of which public in accordance with the Federal Advisory Committee Act, as would constitute a clearly unwarranted provisions set forth in sections amended (5 U.S.C. App.), notice is invasion of personal privacy. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., hereby given of the following meeting. Name of Committee: Center for Scientific as amended. The grant applications and The meeting will be closed to the Review Special Emphasis Panel; Mobile the discussions could disclose public in accordance with the Health: Technology and Outcomes in Low srobinson on DSK5SPTVN1PROD with NOTICES confidential trade secrets or commercial provisions set forth in sections and Middle Income Countries. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Date: July 13–14, 2015. property such as patentable material, Time: 11:00 a.m. to 5:00 p.m. and personal information concerning as amended. The grant applications and Agenda: To review and evaluate grant individuals associated with the grant the discussions could disclose applications. applications, the disclosure of which confidential trade secrets or commercial Place: National Institutes of Health, 6701 would constitute a clearly unwarranted property such as patentable material, Rockledge Drive, Bethesda, MD 20892 invasion of personal privacy. and personal information concerning (Virtual Meeting). VerDate Sep<11>2014 18:49 Jul 07, 2015 Jkt 235001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 E:\FR\FM\08JYN1.SGM 08JYN1


Document Created: 2018-02-23 09:12:31
Document Modified: 2018-02-23 09:12:31
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 30, 2015.
FR Citation80 FR 39140 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR